This setback ought to be bullish for the flu/COVID combo vaccine programs from MRNA (#msg-174351482) and from SNY/NVAX (#msg-174392861). agree yet MRNA is flat today. Perhaps the market is skeptical of the platform now. GSK also has a program by the way that is not too far behind